AG NPP709 is now available; however, no research has investigated the outcome of AG NPP709 in patients with COPD. As a result, the aim of this study was To judge the efficacy of AG NPP709 in clients with chronic bronchitis kind COPD.Berberine suppresses inflammatory brokers-induced interleukin-1beta and tumor necrosis variable-alpha productions via